Arovella Therapeutics Ltd. announced that Mr. Paul Hopper is stepping down from his role as Non-Executive Chairman on June 30, 2022. Non-Executive Director of Arovella, Dr Elizabeth Stoner will assume the role as interim Chairperson, while the company engages in a search for a replacement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.15 AUD | -3.23% |
|
+7.14% | +30.43% |
Jun. 13 | Arovella Therapeutics, Teva Pharmaceuticals End ZolpiMist License Agreement | MT |
Jun. 05 | Arovella Therapeutics Completes Process Development for ALA-101 Manufacturing; Shares Jump 9% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.43% | 106M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- ALA Stock
- News Arovella Therapeutics Limited
- Arovella Therapeutics Ltd Announces Executive Changes